Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

Some children may develop hair loss after having COVID-19.

Low-level laser therapy can significantly regrow hair in alopecia areata.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Greying hairs may be protected from alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Hair transplantation effectively treated a bald patch in an 18-year-old woman with Temporal Triangular Alopecia.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Ayurvedic treatments can effectively regrow hair in Alopecia Areata without side effects.

Male gender and family history predict alopecia areata recurrence.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

The man's skin condition was finally identified as tinea incognito, a fungal infection.

No single treatment is consistently effective for alopecia areata, and more research is needed.